RBC Bioscience Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	219.71	205.25	172.47	173.89	251.18
Revenue Growth (YoY)	7.05%	19.00%	-0.82%	-30.77%	-56.33%
Cost of Revenue	118.25	107.17	99.57	100.89	134.11
Gross Profit	101.46	98.07	72.9	73.01	117.07
Selling, General & Admin	49.02	52.42	47.41	49.61	52.44
Research & Development	17.33	9.86	10.84	15.74	16.39
Operating Expenses	66.43	62.69	58.36	65.26	68.46
Operating Income	35.03	35.38	14.54	7.75	48.61
Interest Expense	-9.69	-10.31	-10	-7.57	-6.33
Interest & Investment Income	0.4	0.5	0.36	0.16	0.17
Other Non Operating Income (Expenses)	4.06	2.88	3	4.57	-5.98
EBT Excluding Unusual Items	29.8	28.45	7.89	4.91	36.48
Gain (Loss) on Sale of Assets	-	0	-0.02	0.01	-0.54
Legal Settlements	-	-1.49	-	-	-
Other Unusual Items	-	-	-	-	0.01
Pretax Income	29.8	26.96	7.87	4.92	35.95
Income Tax Expense	6.25	5.4	1.44	1.14	7.22
Net Income	23.54	21.57	6.43	3.78	28.73
Net Income to Common	23.54	21.57	6.43	3.78	28.73
Net Income Growth	9.17%	235.40%	70.20%	-86.85%	-79.75%
Shares Outstanding (Basic)	14	14	14	14	13
Shares Outstanding (Diluted)	14	14	14	14	14
Shares Change (YoY)	-0.07%	0.43%	-0.08%	5.81%	2.28%
EPS (Basic)	1.65	1.51	0.45	0.26	2.21
EPS (Diluted)	1.64	1.50	0.45	0.26	2.13
EPS Growth	9.33%	236.70%	69.01%	-87.61%	-80.17%
Free Cash Flow	34.08	53.8	8.21	-3.36	-475.02
Free Cash Flow Per Share	2.37	3.75	0.57	-0.23	-35.11
Dividend Per Share	-	0.509	0.400	1.018	0.827
Dividend Growth	-	27.27%	-60.71%	23.19%	-82.05%
Gross Margin	46.18%	47.78%	42.27%	41.98%	46.61%
Operating Margin	15.94%	17.24%	8.43%	4.46%	19.35%
Profit Margin	10.72%	10.51%	3.73%	2.17%	11.44%
Free Cash Flow Margin	15.51%	26.21%	4.76%	-1.93%	-189.12%
EBITDA	51.67	51.6	31.86	25.04	61.47
EBITDA Margin	23.52%	25.14%	18.47%	14.40%	24.47%
D&A For EBITDA	16.65	16.22	17.32	17.29	12.86
EBIT	35.03	35.38	14.54	7.75	48.61
EBIT Margin	15.94%	17.24%	8.43%	4.46%	19.35%
Effective Tax Rate	20.99%	20.01%	18.33%	23.15%	20.08%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.